Anzeige
Mehr »
Mittwoch, 02.07.2025 - Börsentäglich über 12.000 News
Nach dem Genius Act: Dieses börsennotierte XRP-Unternehmen greift im Token-Finanzmarkt an!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von RTTNews

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DoSiTime Prices Follow-on Public Offering Of 1.75 Mln Shares At $200/Shr
DoGolar LNG To Offer $500 Mln Of Convertible Senior Notes Due 2030
DoCheniere Energy Partners Prices $1 Bln Senior Notes Due 2035
DoAlimentation Couche-Tard Q4 Profit Down
DoBurcon NutraScience Corp. Full Year Earnings Summary
DoKewaunee Scientific Corp. Q4 Profit Declines
DoGalderma Launches Phase II Trials Of Nemolizumab For Systemic Sclerosis And CPUO
DoForte Biosciences Prices $75 Mln Public Offering Of Common Stock And Pre-Funded Warrants
25.06.Steelcase Inc Q1 Profit Increases, Beats Estimates
25.06.Addex Shareholders Approve All Board Proposals At 2025 AGM
25.06.Aclarion Enrolls First Patient In CLARITY Trial Evaluating Nociscan In Spine Surgery
25.06.Jefferies Group Inc. Profit Declines In Q2
25.06.HB Fuller Co Reports Drop In Q2 Bottom Line
25.06.Champion Iron Launches US$450 Mln Senior Notes Offering Due 2032
25.06.GlucoTrack Stock Jumps 40% On Strong Clinical Data For Implantable Glucose Monitor
25.06.Urgent.ly Stock Soars Over 52%
25.06.SolarEdge Expands U.S. Manufacturing With New Battery Facility In Utah
25.06.Lifeward Prices $2.6 Mln Public Offering With Warrants At $0.65 Per Share
25.06.Paychex Shares Drop Over 7% On Weaker Q4 Earnings
25.06.Paycom Shares Slide Nearly 5% Despite Strong ROI Study Results
25.06.Bumble To Cut 30% Of Workforce In Strategic Realignment
25.06.Cheniere Energy Partners To Offer Senior Notes, Due 20235
25.06.Bumble To Lay Off About 240 Employees Worldwide
25.06.Plus Therapeutics Stock Gains As FDA Clears REYOBIQ IND Application To Treat Pediatric Brain Cancers
25.06.EnGene Gets RMAT Status For Detalimogene In High-Risk, Non-Muscle Invasive Bladder Cancer